Research and Development
AstraZeneca’s Brilinta fails to best aspirin in treating stroke patients
March 23, 2016 Research and Development AstraZeneca, Brilinta, stroke
Federal jury rules in MSD’s favour in Gilead blockbuster hepatitis C drug dispute
March 23, 2016 Medical Communications, Research and Development Gilead, MSD, blockbuster, federal court, federal jury, hit, patents, sales, sales hit, sofosbuvir, sovaldi
FDA approves Lilly’s plaque psoriasis drug Taltz
March 23, 2016 Research and Development, Sales and Marketing Eli Lilly, Enbrel, Taltz, plaque psoriasis
FDA announces strongest warnings for opioid pain medications
March 23, 2016 Medical Communications, Research and Development FDA, abuse, addiction, boxed, label, misuse, opioids, public health, restrictions, safety, warnings
NICE draft guidance says ‘no’ to cystic fibrosis drug Orkambi
March 23, 2016 Research and Development, Sales and Marketing NICE, Orkambi, Vertex, cystic fibrosis
Targeted cancer therapies can suppress T cell immune responses, study finds
March 23, 2016 Research and Development T cell, anti-cancer drugs, immunosuppresive, superagonist, wistar institute
Celyad teams-up with Institut Curie to advance its immuno-oncology program
March 22, 2016 Manufacturing and Production, Research and Development Cancer Immunotherapy, Celyad, Institut Curie, cellular immunotherapies
Eisai withdraws application for neurodegenerative-disease drug in Japan
March 22, 2016 Manufacturing and Production, Research and Development Eisai, mecobalamin, neurodegenerative disease
BioMarin reports mixed Phase III results for genetic disorder trial-drug Pegvaliase
March 22, 2016 Manufacturing and Production, Research and Development
Darzalex to be trialled in combination with atezolizumab in multiple myeloma and solid tumours
March 22, 2016 Research and Development Genentech, Genmab, Janssen, Roche, atezolizumab, clnical trials, multiple myeloma, phase ib, solid tumours, tumour
Raptor’s Procysbi gets Priority Review from Health Canada
March 22, 2016 Manufacturing and Production, Research and Development Canada, Health Canada, Procysbi, Raptor Pharmaceutical, genetic condition
23andMe’s apps to aid genetic research for Apple’s ResearchKit
March 22, 2016 Manufacturing and Production, Research and Development 23andME, Apple, genetics, research
Sosei appoints Peter Bains as COO and CEO-elect
March 22, 2016 Research and Development
Albumedix technology extends dosing interval in Behring haemophilia B drug
March 22, 2016 Manufacturing and Production, Research and Development Albumedix, GSK, Idelvion, Novozymes, VELTIS, haemophilia B
FDA approves new anthrax treatment
March 22, 2016 Manufacturing and Production, Research and Development Antibacterial, FDA, US, anthim, anthrax, defense, inhalational
